Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,798,537 papers from all fields of science
Search
Sign In
Create Free Account
Palladium-Bacteriochlorophyll Derivative WST11
Known as:
WST11
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Padeliporfin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Medium-term Follow-up of Vascular-targeted Photodynamic Therapy of Localized Prostate Cancer Using TOOKAD Soluble WST-11 (Phase II Trials).
A. Noweski
,
A. Roosen
,
+8 authors
A. Azzouzi
European Urology Focus
2019
Corpus ID: 4900161
2018
2018
WST11 Vascular Targeted Photodynamic Therapy Effect Monitoring by Multispectral Optoacoustic Tomography (MSOT) in Mice
V. Neuschmelting
,
Kwanghee Kim
,
+6 authors
V. Ntziachristos
Theranostics
2018
Corpus ID: 370329
Objective: Monitoring emerging vascular-targeted photodynamic therapy (VTP) and understanding the time-dynamics of treatment…
Expand
Review
2016
Review
2016
Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the…
S. Taneja
,
J. Bennett
,
+6 authors
M. Emberton
Journal of Urology
2016
Corpus ID: 2376048
Highly Cited
2015
Highly Cited
2015
Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11‐vascular‐targeted photodynamic (VTP) therapy
C. Moore
,
A. Azzouzi
,
+10 authors
M. Emberton
BJU International
2015
Corpus ID: 21594472
To determine the optimal drug and light dose for prostate ablation using WST11 (TOOKAD® Soluble) for vascular‐targeted…
Expand
2011
2011
A model to estimate the outcome of prostate cancer photodynamic therapy with TOOKAD Soluble WST11
N. Betrouni
,
Renaud Lopes
,
P. Puech
,
P. Colin
,
S. Mordon
Physics in Medicine and Biology
2011
Corpus ID: 5345927
Interstitial photodynamic therapy is becoming an interesting modality to treat some early stage prostate cancers. A light…
Expand
2011
2011
Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostate.
S. Chevalier
,
M. Anidjar
,
+6 authors
M. Elhilali
Journal of Urology
2011
Corpus ID: 24369274
Highly Cited
2009
Highly Cited
2009
Photocatalytic generation of oxygen radicals by the water-soluble bacteriochlorophyll derivative WST11, noncovalently bound to serum albumin.
I. Ashur
,
Ruth Goldschmidt
,
+4 authors
A. Scherz
Journal of Physical Chemistry A
2009
Corpus ID: 25882067
Light-induced radical generation is the hallmark of fundamental processes and many applications including photosynthesis and…
Expand
2008
2008
Vascular targeted photodynamic therapy for localized prostate cancer.
H. Lepor
Reviews in urology
2008
Corpus ID: 12536429
Survival for men diagnosed with prostate cancer directly depends on the stage and grade of the disease at diagnosis. Prostate…
Expand
Highly Cited
2005
Highly Cited
2005
WST11, A Novel Water-soluble Bacteriochlorophyll Derivative; Cellular Uptake, Pharmacokinetics, Biodistribution and Vascular-targeted Photodynamic Activity Using Melanoma Tumors as a Model¶
O. Mazor
,
A. Brandis
,
+4 authors
A. Scherz
Photochemistry and Photobiology
2005
Corpus ID: 3169835
Abstract WST11 is a novel negatively charged water-soluble palladium-bacteriochlorophyll derivative that was developed for…
Expand
2005
2005
Novel Water‐soluble Bacteriochlorophyll Derivatives for Vascular‐targeted Photodynamic Therapy: Synthesis, Solubility, Phototoxicity and the Effect of Serum Proteins ¶
A. Brandis
,
O. Mazor
,
E. Neumark
,
V. Rosenbach‐Belkin
,
Y. Salomon
,
A. Scherz
Photochemistry and Photobiology
2005
Corpus ID: 4816820
New negatively charged water‐soluble bacteriochlorophyll (Bchl) derivatives were developed in our laboratory for vascular…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE